• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Insmed Incorporated - Common Stock (NQ:INSM)

    147.15 -1.46 (-0.98%)
    Streaming Delayed Price Updated: 11:21 AM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 474,729
    Open 147.00
    Bid (Size) 147.05 (200)
    Ask (Size) 147.25 (200)
    Prev. Close 148.61
    Today's Range 146.69 - 149.57
    52wk Range 60.40 - 212.75
    Shares Outstanding 115,246,666
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗
    Praxis Precision Medicines develops therapies for neurological and psychiatric disorders, aiming to address unmet needs in the CNS market. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗
    GRAIL develops advanced cancer detection technologies, serving healthcare providers and individuals seeking early diagnostic solutions. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -16.9%
    -16.9%
    1 Month
    -7.9%
    -7.9%
    3 Month
    -28.0%
    -28.0%
    6 Month
    +9.4%
    +9.4%
    1 Year
    +89.9%
    +89.9%

    More News

    Read More
    News headline image
    Insmed (INSM) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗
    Via The Motley Fool
    Topics Stocks
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit ↗
    Via Stocktwits
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute
    News headline image
    Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
    From BioMedWire
    Via GlobeNewswire
    News headline image
    30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Billionaire Stanley Druckenmiller Just Bet Big on This Hot IPO Stock. Is It a Buy? ↗
    Via The Motley Fool
    Topics ETFs Initial Public Offering Regulatory Compliance
    News headline image
    Peering Into Insmed Inc's Recent Short Interest ↗
    Via Benzinga

    Frequently Asked Questions

    Is Insmed Incorporated - Common Stock publicly traded?
    Yes, Insmed Incorporated - Common Stock is publicly traded.
    What exchange does Insmed Incorporated - Common Stock trade on?
    Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Insmed Incorporated - Common Stock?
    The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market
    What is the current price of Insmed Incorporated - Common Stock?
    The current price of Insmed Incorporated - Common Stock is 147.15
    When was Insmed Incorporated - Common Stock last traded?
    The last trade of Insmed Incorporated - Common Stock was at 02/26/26 11:21 AM ET
    What is the market capitalization of Insmed Incorporated - Common Stock?
    The market capitalization of Insmed Incorporated - Common Stock is 16.96B
    How many shares of Insmed Incorporated - Common Stock are outstanding?
    Insmed Incorporated - Common Stock has 17B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.